RICH GOLDMAN (00070) issues profit warning, expects annual loss of approximately HK$21 million
RICH GOLDMAN (00070) issued an announcement that the Group is expected to record a loss of approximately HK$21 million for the financial year ended 30 June 2026 (FY2026), compared with a loss of approximately HK$102 million for the financial year ended 30 June 2025 (FY2025).
RICH GOLDMAN (00070) has announced that the Group is expected to record a loss of approximately HK$21 million for the financial year ended 30 June 2026 (FY2026), compared to a loss of approximately HK$102 million for the financial year ended 30 June 2025 (FY2025).
The expected decrease in loss for FY2026 was primarily attributable to a reversal of impairment loss of approximately HK$3 million recognised in FY2026 in respect of the Group's hotel property classified as property, plant and equipment, as opposed to an impairment loss of approximately HK$39 million in FY2025; a decrease of approximately HK$28 million in the fair value loss on the Group's investment properties as compared to FY2025; and a decrease of approximately HK$8 million in the impairment provision and write-off in respect of the Group's loans receivable and interest receivable as compared to FY2025. The above reversal of impairment loss, fair value loss, impairment provision and write-off are all non-cash accounting treatment items in compliance with HKFRS Accounting Standards, and each of them has no impact on the Group's operating cash flow.
Related Articles

MEGA GENOMICS (06667) repurchased 109,800 shares for HKD 768,200 on September 18.

YUEXIU PROPERTY (00123): The coupon rate for Tranche II of Guangzhou City Construction and Development Co., Ltd.'s 2026 publicly issued corporate bonds (Fourth Tranche) to professional investors is 1.92%.

RICI HEALTH (01526) repurchased 30,000 shares for HK$26,200 on September 18.
MEGA GENOMICS (06667) repurchased 109,800 shares for HKD 768,200 on September 18.

YUEXIU PROPERTY (00123): The coupon rate for Tranche II of Guangzhou City Construction and Development Co., Ltd.'s 2026 publicly issued corporate bonds (Fourth Tranche) to professional investors is 1.92%.

RICI HEALTH (01526) repurchased 30,000 shares for HK$26,200 on September 18.

RECOMMEND





